共 115 条
[1]
Romão VC(2014)Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity? Immunol Res 60 289-310
[2]
Lima A(2019)Acute versus chronic methotrexate poisoning; a cross-sectional study BMC Pharmacol Toxicol 20 1-7
[3]
Bernardes M(2003)Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis Ann Rheum Dis 62 423-426
[4]
Canhão H(2001)Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight-week, multicenter, randomized, double-blind, placebo-controlled study Arthritis Rheum 44 1515-1524
[5]
Fonseca JE(2009)Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review Br J Dermatol 160 622-628
[6]
Ahmadzadeh A(2009)Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research Ann Rheum Dis 68 1100-1104
[7]
Zamani N(2020)Adverse effects of low-dose methotrexate: a randomized trial Ann Intern Med 172 369-380
[8]
Hassanian-Moghaddam H(2017)Investigating methotrexate toxicity within a randomized double- blinded, placebo-controlled trial: rationale and design of the cardiovascular inflammation reduction trial-adverse events (CIRT-AE) study Semin Arthritis Rheum 47 133-142
[9]
Hadeiy SK(2016)Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers Nat Rev Rheumatol 12 731-742
[10]
Parhizgar P(2014)Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients Autoimmun Rev 13 1109-1113